Sichuan Hebang Biotechnology Co Ltd (603077) — Financial Flexibility Index
Sichuan Hebang Biotechnology Co Ltd (603077) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥366.16 Million (operating CF CN¥165.40 Million minus capex CN¥200.76 Million) represents 0% of total liabilities (CN¥10.53 Billion). Check 603077 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sichuan Hebang Biotechnology Co Ltd Financial Flexibility Index (2009–2024)
Historical Financial Flexibility Index trend for Sichuan Hebang Biotechnology Co Ltd across 16 annual periods. See working capital to net assets of Sichuan Hebang Biotechnology Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Sichuan Hebang Biotechnology Co Ltd (2009–2024)
Year-by-year free cash flow to debt coverage for Sichuan Hebang Biotechnology Co Ltd. For the full company profile including market capitalisation, see market cap of Sichuan Hebang Biotechnology Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.15x | CN¥1.58 Billion | CN¥467.93 Million | CN¥10.64 Billion | ▼ -37.5% |
| 2023 | 0.24x | CN¥1.03 Billion | CN¥200.76 Million | CN¥4.32 Billion | ▼ -71.1% |
| 2022 | 0.83x | CN¥3.58 Billion | CN¥2.64 Billion | CN¥4.34 Billion | ▼ -45.0% |
| 2021 | 1.50x | CN¥4.93 Billion | CN¥3.20 Billion | CN¥3.29 Billion | ▲ +810.5% |
| 2020 | 0.16x | CN¥565.95 Million | CN¥368.85 Million | CN¥3.43 Billion | ▼ -39.5% |
| 2019 | 0.27x | CN¥825.46 Million | CN¥162.92 Million | CN¥3.03 Billion | ▼ -56.5% |
| 2018 | 0.63x | CN¥1.31 Billion | CN¥944.39 Million | CN¥2.09 Billion | ▲ +67.6% |
| 2017 | 0.37x | CN¥685.48 Million | CN¥176.94 Million | CN¥1.83 Billion | ▼ -35.8% |
| 2016 | 0.58x | CN¥1.25 Billion | CN¥575.26 Million | CN¥2.15 Billion | ▲ +70.1% |
| 2015 | 0.34x | CN¥1.58 Billion | CN¥449.20 Million | CN¥4.62 Billion | ▲ +62.7% |
| 2014 | 0.21x | CN¥921.44 Million | CN¥204.67 Million | CN¥4.38 Billion | ▲ +152.4% |
| 2013 | 0.08x | CN¥191.06 Million | CN¥-407.48 Million | CN¥2.29 Billion | ▼ -66.5% |
| 2012 | 0.25x | CN¥408.79 Million | CN¥134.96 Million | CN¥1.64 Billion | ▼ -35.1% |
| 2011 | 0.38x | CN¥897.73 Million | CN¥552.56 Million | CN¥2.34 Billion | ▼ -8.8% |
| 2010 | 0.42x | CN¥901.77 Million | CN¥330.77 Million | CN¥2.14 Billion | ▲ +11.4% |
| 2009 | 0.38x | CN¥917.49 Million | CN¥68.97 Million | CN¥2.43 Billion | — |